LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Life-Threatening Serotonin Syndrome Due to Methylene Blue-Citalopram Interaction.

Photo by gaurav_rawat from unsplash

1. Couturier MR, Slechta ES, Goulston C, et al. Leptotrichia bacteremia in patients receiving high-dose chemotherapy. J Clin Microbiol. 2012;50:1228–1232. 2. Caballero MD, Rubio V, Rifon J, et al. BEAM… Click to show full abstract

1. Couturier MR, Slechta ES, Goulston C, et al. Leptotrichia bacteremia in patients receiving high-dose chemotherapy. J Clin Microbiol. 2012;50:1228–1232. 2. Caballero MD, Rubio V, Rifon J, et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transpl. 1997;20:451–458. 3. Faderl S, Ravandi F, Huang X, et al. A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood. 2008;112:1638–1645. 4. Zebrowski A, Hanlon A, Mangan J, et al. Clofarabine busulfan conditioning improves outcomes in patients with active acute myelogenous leukemia undergoing allogeneic stem cell transplant. Blood. 2014;124:1239. 5. Stein EM, DiNardo CD, Pollyea DA, et al. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. Blood. 2017;130:722–731. 6. Ronchetti AM, Isnard F, Buffet M, et al. Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents. Leuk Lymphoma. 2013;54:1117–1119. 7. Nadiminti K, Singh Abbi KK, Mott SL, et al. VTDmelphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma. Oncotargets Ther. 2017;10:217–226. 8. Weinberger M, Wu T, Rubin M, et al. Leptotrichia buccalis bacteremia in patients with cancer: report of four cases and review. Rev Infect Dis. 1991;13:201–206. 9. Kohler JL, Raoult D, Gallais H, et al. Septicemia due to Leptotrichia buccalis in an immuno-suppressed patent (author’s transl) [in French]. Pathol Biol. 1982;30:161–162. 10. Eribe ER, Olsen I. Leptotrichia species in human infections. Anaerobe 2008;14:131–137. 11. Schrimsher JM, McGuirk JP, Hinthorn DR. Leptotrichia trevisanii sepsis after bone marrow transplantation. Emerg Infect Dis. 2013;19:1690–1691. 12. Luo AH, Yang DQ, Xin BC, et al. Microbial profiles in saliva from children with and without caries in mixed dentition. Oral Dis. 2012;18:595–601. 13. Martín-Guti errez G, Rodríguez N, Lepe JA, et al. Rapid identification of a Leptotrichia trevisanii catheter-related bloodstream infection using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. JMM Case Rep. 2015;2:1–4. 14. Ruviere DB, Leonardo MR, da Silva LA, et al. Assessment of the microbiota in root canals of human primary teeth by checkerboard DNA-DNA hybridization. J Dent Child. 2007;74:118–123. 15. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56–93.

Keywords: threatening serotonin; leptotrichia; infect dis; syndrome; life threatening

Journal Title: American Journal of Therapeutics
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.